| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA)
KNSA Technical Analysis
5
| As on 9th Jun 2023 KNSA STOCK Price closed @ 15.05 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 11.10 & Strong Buy for SHORT-TERM with Stoploss of 11.14 we also expect STOCK to react on Following IMPORTANT LEVELS. |
KNSASTOCK Price
| Open | 14.87 | Change | Price | % |
| High | 15.15 | 1 Day | 0.02 | 0.13 |
| Low | 14.56 | 1 Week | 1.38 | 10.10 |
| Close | 15.05 | 1 Month | 3.90 | 34.98 |
| Volume | 256649 | 1 Year | 1.77 | 13.33 |
| 52 Week High 17.05 | 52 Week Low 7.60 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| KNSA Daily Charts |
KNSA Intraday Charts |
Whats New @ Bazaartrend |
KNSA Free Analysis |
|
|
KNSA Important Levels Intraday
| RESISTANCE | 16.19 |
| RESISTANCE | 15.82 |
| RESISTANCE | 15.60 |
| RESISTANCE | 15.37 |
| SUPPORT | 14.73 |
| SUPPORT | 14.50 |
| SUPPORT | 14.28 |
| SUPPORT | 13.91 |
KNSA Forecast May 2024
| 4th UP Forecast | 19.44 |
| 3rd UP Forecast | 18.03 |
| 2nd UP Forecast | 17.16 |
| 1st UP Forecast | 16.29 |
| 1st DOWN Forecast | 13.81 |
| 2nd DOWN Forecast | 12.94 |
| 3rd DOWN Forecast | 12.07 |
| 4th DOWN Forecast | 10.66 |
KNSA Weekly Forecast
| 4th UP Forecast | 19.27 |
| 3rd UP Forecast | 17.92 |
| 2nd UP Forecast | 17.08 |
| 1st UP Forecast | 16.24 |
| 1st DOWN Forecast | 13.86 |
| 2nd DOWN Forecast | 13.02 |
| 3rd DOWN Forecast | 12.18 |
| 4th DOWN Forecast | 10.83 |
KNSA Forecast2024
| 4th UP Forecast | 34.01 |
| 3rd UP Forecast | 27.93 |
| 2nd UP Forecast | 24.17 |
| 1st UP Forecast | 20.41 |
| 1st DOWN Forecast | 9.69 |
| 2nd DOWN Forecast | 5.93 |
| 3rd DOWN Forecast | 2.17 |
| 4th DOWN Forecast | -3.91 |
Kiniksa Pharmaceuticals Ltd ( NASDAQ USA Symbol : KNSA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
KNSA Business Profile
Kiniksa Pharmaceuticals, Ltd., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need worldwide. Its product candidates include Rilonacept, which is in Phase III clinical trials for the treatment of recurrent pericarditis, an inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody that is in Phase II clinical trials for the treatment of giant cell arteritis; and Vixarelimab, a monoclonal antibody, which is in Phase 2a clinical trial for the treatment of prurigo nodularis, a chronic inflammatory skin condition. The company's preclinical product candidates comprise KPL-404, a monoclonal antibody inhibitor of the CD40/CD40L interaction, a central control node of T-cell-dependent, and B-cell-mediated humoral adaptive immunity. The company has a clinical collaboration with Kite Pharma, Inc. to evaluate the combination of Yescarta and Mavrilimumab in patients with relapsed or refractory Large B-Cell lymphoma. Kiniksa Pharmaceuticals, Ltd. was founded in 2015 and is based in Hamilton, Bermuda. Address: Clarendon House, Hamilton, Bermuda, HM 11
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service